Clinical Trials Browser

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

Clinical Trials

Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

PRISM

Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC

A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma

Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma

TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona

Treat Primary and Metastatic Liver Tumors

A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma

Treat-and-resect Study of Echo Decorrelation Imaging-controlled Radiofrequency Ablation in Liver Tumors

HCC

Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer

PANORAMA2

Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE

Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy

Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery

Y-90 Versus SBRT for Inoperable HCC

FDGal PET/CT to Detect Hepatocellular Carcinoma

Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells

LIDA-ADJ

Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma

A Study to Evaluate Vaccines Against COVID-19 in the Real World

A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation

ECHAPS

A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC

BIOPEARL-FIRST

BCAA in HCC

Adjuvant Therapy With Anlotinib for HCC

Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMI™) Loaded With Doxorubicin

Microwave Ablation of Resectable Liver Tumors

Irreversible Electroporation of Unresectable Liver Tumors

TheraBionics

Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1

IRAL

Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic Vessels

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry

The Safety and Efficacy of Spherical Microwave Ablation for the Treatment of Malignant Liver Tumors

HATCHeT

CAR-T Cell Immunotherapy for HCC Targeting GPC3

STOP-HCC

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)

Vancomycin in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLC) Oral

A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer

Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation

Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction

In-Situ Therapeutic Cancer Vaccine for Refractory Liver Cancer